Concepedia
Statistics
Publications
4
Citations
144
H-Index
Active since
2018
Affiliations
Seoul National University(Current)
Seoul National University Hospital
Regeneron (United States)
Columbia University Irving Medical Center
Ha-Ram Park is an author at Seoul National University specializing in pathology, oncology, and pharmacotherapy.
Top concepts
MedicineOncologyPathologyPharmacologyCancer GeneticsPharmacotherapy
Publications per year
2018–2023
Inhibition of MEK with trametinib enhances the efficacy of anti-PD-L1 inhibitor by regulating anti-tumor immunity in head and neck squamous cell carcinoma
Seong-Ho Kang, Bhumsuk Keam, Yong‐Oon Ahn et al. · OncoImmunology · 2018 · 69 citations · Full text
Angiopoietin-2–Dependent Spatial Vascular Destabilization Promotes T-cell Exclusion and Limits Immunotherapy in Melanoma
Ha-Ram Park, Anahita Shiva, Portia Cummings et al. · Cancer Research · 2023 · 38 citations · Full text
Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors in Patients With De Novo EGFRT790M-Mutant NSCLC
Ha-Ram Park, Tae Min Kim, Yusoo Lee et al. · Journal of Thoracic Oncology · 2021 · 25 citations · Full text
Medicine, Receptor Tyrosine Kinase, Pharmacology +5
Angiopoietin-2 blockade suppresses growth of liver metastases from pancreatic neuroendocrine tumors by promoting T cell recruitment
Eunhyeong Lee, Sophie O'Keefe, Alessandra Leong et al. · Journal of Clinical Investigation · 2023 · 12 citations · Full text
1–4 of 4